The testing of the coronary vaccine gives the first promising signs

The first signs that a vaccine can prepare the human immune system to fight for Coddy-19 were reported by a company in the United States. Moderna said neutral antibodies were found in the first eight persons to have participated in the test. The company also said the immune response has been [...]
Moderna said neutral antibodies were found in the first eight persons to have participated in the test.
The company also said the immune response has been similar to people infected with the current virus.
Greater tests to see if the vaccine actually protects against infection are expected to begin in July.
Work on creating a coronary vaccine is rapidly developing, about 80 groups worldwide are making efforts.
Modern is the first to test an experimental vaccine called mRNA-1273, in humans.
The vaccine is a small part of the Coronobrus genetic code that is injected into the patient.
It does not have the capacity to cause infection or symptoms of coronary, but it is sufficient to stimulate reactions from the immune system.
Tests of the vaccine, led by the U.S. Government's Institute for Allergy and Infectious Diseases, indicated that it leads to the production of antibodies that can neutralise the coronary.
However, the test has only been done in the first eight people.
Coronavirus has affected over 4.7 million people worldwide, while about 317,000 have lost their lives.












